Literature DB >> 21283453

Dysfunctional uterine bleeding.

R F Casper.   

Abstract

Dysfunctional uterine bleeding is most commonly associated with chronic anovulation. Early diagnosis of anovulation is important; the induction of regular withdrawal periods using a progestin such as Provera prevents the development of endometrial hyperplasia with the subsequent inevitable occurrence of a heavy, frightening vaginal bleed. The etiology of dysfunctional uterine bleeding occurring during ovulatory cycles is unknown and all medical therapies at present are necessarily experimental. Hysterectomy is probably the treatment of choice for women who have finished their childbearing career and in whom persisting menorrhagia during ovulatory cycles results in anemia.

Entities:  

Year:  1983        PMID: 21283453      PMCID: PMC2154129     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  14 in total

1.  Initiation of human parturition. IV. Demonstration of phospholipase A2 in the lysosomes of human fetal membranes.

Authors:  B E Schwarz; F M Schultz; P C MacDonald; J M Johnston
Journal:  Am J Obstet Gynecol       Date:  1976-08-15       Impact factor: 8.661

2.  Initiation of human parturition. I. Mechanism of action of arachidonic acid.

Authors:  P C MacDonald; F M Schultz; J H Duenhoelter; N F Gant; J M Jimenez; J A Pritchard; J C Porter; J M Johnston
Journal:  Obstet Gynecol       Date:  1974-11       Impact factor: 7.661

3.  Treatment of menorrhagia with tranexamic acid. A double-blind trial.

Authors:  S T Callender; G T Warner; E Cope
Journal:  Br Med J       Date:  1970-10-24

4.  Naproxen in menorrhagia.

Authors:  G Rybo; S Nilsson; B Sikström; K G Nygren
Journal:  Lancet       Date:  1981-03-14       Impact factor: 79.321

5.  Treatment of menorrhagia.

Authors:  L Nilsson; G Rybo
Journal:  Am J Obstet Gynecol       Date:  1971-07-01       Impact factor: 8.661

6.  Endometrial effects of levonorgestrel and estradiol: A Scanning electron microscopic study of the luminal epithelium.

Authors:  O Nilsson; D Englund; E Weiner; A Victor
Journal:  Contraception       Date:  1980-07       Impact factor: 3.375

7.  Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices.

Authors:  O Ylikorkala; A Kauppila; M Siljander
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

8.  Menstrual blood loss--a population study. Variation at different ages and attempts to define normality.

Authors:  L Hallberg; A M Högdahl; L Nilsson; G Rybo
Journal:  Acta Obstet Gynecol Scand       Date:  1966       Impact factor: 3.636

9.  Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors.

Authors:  A B Anderson; P J Haynes; J Guillebaud; A C Turnbull
Journal:  Lancet       Date:  1976-04-10       Impact factor: 79.321

10.  Acute adolescent menorrhagia.

Authors:  E A Claessens; C A Cowell
Journal:  Am J Obstet Gynecol       Date:  1981-02-01       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.